| FKBP binding characteristics of cardiac microsomes from diverse vertebrates LH Jeyakumar, L Ballester, DS Cheng, JO McIntyre, P Chang, HE Olivey, ... Biochemical and biophysical research communications 281 (4), 979-986, 2001 | 139 | 2001 |
| Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma A Rajan, CR Heery, A Thomas, AL Mammen, S Perry, G O’Sullivan Coyne, ... Journal for immunotherapy of cancer 7, 1-12, 2019 | 116 | 2019 |
| Advances in clinical next-generation sequencing: target enrichment and sequencing technologies LY Ballester, R Luthra, R Kanagal-Shamanna, RR Singh Expert Review of Molecular Diagnostics 16 (3), 357-372, 2016 | 101 | 2016 |
| Cerebral radiation necrosis: incidence, pathogenesis, diagnostic challenges, and future opportunities FS Ali, O Arevalo, S Zorofchian, A Patrizz, R Riascos, N Tandon, A Blanco, ... Current oncology reports 21, 1-17, 2019 | 92 | 2019 |
| Multi-omics integration analysis robustly predicts high-grade patient survival and identifies CPT1B effect on fatty acid metabolism in bladder cancer V Vantaku, J Dong, CR Ambati, D Perera, SR Donepudi, CS Amara, ... Clinical Cancer Research 25 (12), 3689-3701, 2019 | 92 | 2019 |
| Cognitive disability in adult patients with brain tumors FS Ali, MR Hussain, C Gutiérrez, P Demireva, LY Ballester, JJ Zhu, ... Cancer treatment reviews 65, 33-40, 2018 | 77 | 2018 |
| Integrating molecular testing in the diagnosis and management of children with thyroid lesions LY Ballester, SF Sarabia, H Sayeed, N Patel, J Baalwa, I Athanassaki, ... Pediatric and Developmental Pathology 19 (2), 94-100, 2016 | 77 | 2016 |
| Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas LY Ballester, Z Wang, S Shandilya, M Miettinen, PC Burger, CG Eberhart, ... The American journal of surgical pathology 37 (9), 1357-1364, 2013 | 76 | 2013 |
| Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma AK Park, P Kim, LY Ballester, Y Esquenazi, Z Zhao Neuro-oncology 21 (1), 59-70, 2019 | 71 | 2019 |
| Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma S Ahsan, EH Raabe, MC Haffner, A Vaghasia, KE Warren, M Quezado, ... Acta neuropathologica communications 2, 1-9, 2014 | 67 | 2014 |
| Polymorphic ventricular tachycardia and KCNJ2 mutations TUH Chun, MR Epstein, M Dick II, G Andelfinger, L Ballester, CG Vanoye, ... Heart Rhythm 1 (2), 235-241, 2004 | 67 | 2004 |
| Up-regulation of the Neuronal Nicotinic Receptor α7 by HIV Glycoprotein 120 LY Ballester, CM Capó-Vélez, WF García-Beltrán, FM Ramos, ... Journal of Biological Chemistry 287 (5), 3079-3086, 2012 | 65 | 2012 |
| Evaluating circulating tumor DNA from the cerebrospinal fluid of patients with melanoma and leptomeningeal disease LY Ballester, IC Glitza Oliva, DY Douse, MM Chen, C Lan, LE Haydu, ... Journal of Neuropathology & Experimental Neurology 77 (7), 628-635, 2018 | 64 | 2018 |
| Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma J Li, S Zhao, M Lee, Y Yin, J Li, Y Zhou, LY Ballester, Y Esquenazi, ... Science advances 6 (42), eabb5427, 2020 | 63 | 2020 |
| Trafficking‐competent and trafficking‐defective KCNJ2 mutations in Andersen syndrome LY Ballester, DW Benson, B Wong, IH Law, KD Mathews, CG Vanoye, ... Human mutation 27 (4), 388-388, 2006 | 63 | 2006 |
| Assessment of glioblastoma response in the era of bevacizumab: longstanding and emergent challenges in the imaging evaluation of pseudoresponse OD Arevalo, C Soto, P Rabiei, A Kamali, LY Ballester, Y Esquenazi, ... Frontiers in neurology 10, 460, 2019 | 60 | 2019 |
| Expression and transcriptional control of human KCNE genes AL Lundquist, CL Turner, LY Ballester, AL George Jr Genomics 87 (1), 119-128, 2006 | 54 | 2006 |
| Glioma and temozolomide induced alterations in gut microbiome A Patrizz, A Dono, S Zorofchian, G Hines, T Takayasu, N Husein, Y Otani, ... Scientific reports 10 (1), 21002, 2020 | 48 | 2020 |
| Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors LY Ballester, G Lu, S Zorofchian, V Vantaku, V Putluri, Y Yan, O Arevalo, ... Acta Neuropathologica Communications 6, 1-10, 2018 | 42 | 2018 |
| The use of BRAF V600E mutation‐specific immunohistochemistry in pediatric Langerhans cell histiocytosis LY Ballester, MD Cantu, KPH Lim, SF Sarabia, LS Ferguson, ... Hematological oncology 36 (1), 307-315, 2018 | 42 | 2018 |
